Thu.Aug 15, 2024

article thumbnail

As mpox outbreak spreads across Africa, Siga's antiviral Tpoxx misses the bar in Congo study

Fierce Pharma

Just as a new strain of mpox spreads across Africa, results from a preliminary analysis of a study that began during the 2022 viral outbreak stands to provide more clarity on the clinical benefit o | Despite missing the trial's primary endpoint of time to lesion resolution, the study suggested that the treatment may be most beneficial for those treated early and those with severe disease.

311
311
article thumbnail

What Will the Future of Retail Health Look Like?

MedCity News

Retailers aren’t giving up on healthcare — but they are trying to be more strategic in their efforts to disrupt the space. As these companies re-strategize, experts think they need to center their efforts on building trust and fostering long-term patient engagement. The post What Will the Future of Retail Health Look Like? appeared first on MedCity News.

Retail 131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case

Fierce Pharma

Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the | Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the original lawsuit.

304
304
article thumbnail

CMS Touts First Negotiated Drug Prices, But Greater Impact Expected in Future Rounds

MedCity News

The first 10 drugs selected for Medicare price negotiations now have new prices set to take effect in 2026. Industry observers note that most of these drugs are older products facing generic competition soon, so greater industry impact will come as the program expands to more drugs in years to come. The post CMS Touts First Negotiated Drug Prices, But Greater Impact Expected in Future Rounds appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

B. Braun, Baxter launch separate recalls over particulate concerns and excess endotoxin levels, respectively

Fierce Pharma

So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. | So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. While neither recall has resulted in any safety flags or side effect reports so far, the issues stemming from the faulty products could be severe, the drugmakers have w

article thumbnail

Good Measures, Point32Health Launch Food as Medicine Partnership

MedCity News

Through a new partnership with Good Measures, some Point32Health members have gained access to nutrition counseling, food tracking and other services. The post Good Measures, Point32Health Launch Food as Medicine Partnership appeared first on MedCity News.

Food 122

More Trending

article thumbnail

Streamlined Participant Payments Unlock Clinical Trial Access for All

MedCity News

Participant payment options should include a variety of stipend and micropayment methods to meet participant preferences. Increasing the diversity of payment methods with both banked and unbanked options enhances flexibility, catering to a diverse and international participant base with varying payout needs. The post Streamlined Participant Payments Unlock Clinical Trial Access for All appeared first on MedCity News.

Biopharma 118
article thumbnail

The TROP2 race for supremacy

Fierce Pharma

The TROP2 antibody-drug conjugate race has heated up among three Big Pharma companies: Gi | In this week’s episode of “The Top Line,” Fierce executive editor Eric Sagonowsky chats with Angus Liu about his feature story on the three TROP2 front-runners.

Pharma 147
article thumbnail

AstraZeneca said to be wavering on £450m UK vaccine plant

pharmaphorum

AstraZeneca's plan to invest £450m in a vaccines plant in the UK has been thrown into doubt by a bid to slash state aid, reports FT

115
115
article thumbnail

Back to School and Oral Health

MedCity News

As we send our kids back to school this fall, let’s remember that a healthy smile is about more than looks — it’s about giving our children the best possible start in life, free from the pain and distraction of dental problems, which are likely to occur if left untreated. The post Back to School and Oral Health appeared first on MedCity News.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Incyte builds GvHD presence with Niktimvo approval

pharmaphorum

FDA clears Incyte's potential blockbuster Niktimvo as a treatment for chronic GvHD, making it a companion to the company's Jakafi for the disorder.

FDA 111
article thumbnail

How clinical trials can use AI responsibly and effectively

Pharmaceutical Technology

Strong measures must be in place to safeguard confidential patient data when deploying AI to optimise clinical trial translations.

Patients 107
article thumbnail

AI chatbots struggle to interpret patient descriptions

pharmaphorum

Large language models (LLMs) find it hard to identify genetic conditions based on patient-written descriptions, say NIH researchers.

Patients 111
article thumbnail

Lessons from COVID: Tuskegee impacts still erode trust in healthcare, but hope shines through

PharmaVoice

A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

PBC drug choices rise in US with OK for Gilead's seladelpar

pharmaphorum

FDA approves Gilead's Livdelzi for primary biliary cholangitis, setting up a contest with Ipsen's recent launch Iqirvo in the second-line setting

FDA 105
article thumbnail

McMaster drug trial receives more than $6m to test smallpox vaccine against mpox

PharmaTimes

Children accounted for the majority of mpox cases and deaths in the DRC since June 2023

92
article thumbnail

Theramex's uterine fibroid drug Yselty backed for NHS use

pharmaphorum

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales.

81
article thumbnail

Study identifies new disease-inducing mechanism for inflammatory bowel disease

PharmaTimes

Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK

80
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

CMS Announces Negotiated Prices for 10 Drugs Under Inflation Reduction Act

Pharmacy Times

The new prices are expected to go into effect for patients with Medicare Part D on January 1, 2026.

article thumbnail

Gilead’s PBC therapy Livdelzi bags accelerated approval

Pharmaceutical Technology

Livdelzi is said to be effective against primary biliary cholangitis (PBC) for patients unresponsive to standard-of-care therapy.

article thumbnail

Intelliguard, Cencora Collaborate on Boosting RFID-Tagged Medication Compatibility

Pharmaceutical Commerce

Partnership adds supply chain efficiencies, while prioritizing patient safety.

Medical 59
article thumbnail

Maximizing ROI in Medical and Disease Education Programs: A Marketing Analytics Perspective

Eversana Intouch

In the ever-evolving landscape of healthcare marketing, understanding audience engagement and measuring success is paramount. In a recent PM360 Think Tank article , Iyiola Obayomi, SVP, Managing Director of Analytics, shared his expertise on mastering metrics. Let’s explore key insights from his perspective. Audience-Centric Metrics: Historically, marketers relied on superficial metrics like likes and shares.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses

Pharmacy Times

RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.

58
article thumbnail

Opening the Door: Omvoh

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

FDA Grants Priory Review for Durvalumab to Treat Small Cell Lung Cancer

Pharmacy Times

The supplemental biologics license application was granted based on results from the ADRIATIC phase 3 trial among individuals with limited stage small cell lung cancer.

FDA 52
article thumbnail

Targeted therapies for chronic lymphocytic leukaemia in an evolving treatment landscape

European Pharmaceutical Review

Chronic lymphocytic leukaemia (CLL) is the most prevalent adult leukaemia in Western countries with more than 100,000 incidences and more than 40,000 deaths reported globally in 2019. 1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments.

Safety 52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Experimental Malaria Vaccine Found to be Safe in Multiple Trials in Mali

PharmaTech

National Institutes of Health’s National Institute of Allergy and Infectious Diseases collaborated with the University of Sciences, Techniques and Technologies of Bamako, Mali to conduct the trials.

52
article thumbnail

The Future of Launch Excellence is Generative AI

PharmExec

How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.

article thumbnail

Evotec slashes workforce by 400 people in “difficult market” 

Pharmaceutical Technology

Evotec’s CEO Christian Wojczewski had previously announced a strategic reset after shutting down its gene therapy business earlier this year.

article thumbnail

Questhealth.com Announces 13 New Blood Test for Micronutrients

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A